Dec 09, 2020 / 03:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Infinity Pharmaceuticals 2020 San Antonio Breast Cancer Symposium. (Operator Instructions) I would now like to introduce host of today's conference call, Ms. Jayne Kauffman. You may begin.
Jayne Kauffman - Infinity Pharmaceuticals, Inc. - Senior Executive Coordinator
Good morning, everyone, and welcome to today's call where we will review TNBC data from MARIO-3, which was presented today during the San Antonio Breast Cancer Symposium, or SABC.
Participants on today's call are Adelene Perkins, Chief Executive Officer; and Dr. Brian Schwartz, Consulting Chief Physician from Infinity Pharmaceuticals; and Dr. Erika Hamilton, Director of the Breast Cancer and Gynecologic Cancer Research Program at Sarah Cannon Research Institute at Tennessee Oncology; and MARIO-3 Lead Study Investigator.
During this call, we may make forward-looking statements about our future expectations and plans including clinical development objectives, the therapeutic potential of our product candidates, our
Infinity Pharmaceuticals Inc at 2020 San Antonio Breast Cancer Symposium - Conference Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
